Artificial Intelligence in Cardiology

A Global Strategic Business Report

MCP29253

RESEARCH DASHBOARD

SEP 2025

RELEASE DATE

7091

EXECUTIVE POOL

5850

PRICE

899

EXPERT INPUTS

36

COMPANIES

106

DATA TABLES

172

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Artificial Intelligence in Cardiology Market to Reach US$4.3 Billion by 2030

The global market for Artificial Intelligence in Cardiology estimated at US$1.3 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 22.7% over the analysis period 2024-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 19.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$328.9 Million While China is Forecast to Grow at 21.6% CAGR

The Artificial Intelligence in Cardiology market in the U.S. is estimated at US$328.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$654.1 Million by the year 2030 trailing a CAGR of 21.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.7% and 19.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.7% CAGR.

Global Artificial Intelligence in Cardiology Market - Key Trends & Drivers Summarized

How Is AI Transforming Cardiology Diagnostics and Treatment?

Artificial Intelligence (AI) is revolutionizing cardiology by enabling precise diagnostics, predictive analytics, and personalized treatment strategies. Traditional diagnostic methods in cardiology often rely on manual interpretation of imaging, electrocardiograms (ECGs), and other clinical data, which can be time-consuming and prone to variability. AI addresses these challenges by analyzing large datasets with unparalleled speed and accuracy, identifying patterns and abnormalities that might be overlooked by human practitioners.

For example, AI-powered imaging systems enhance the accuracy of diagnosing conditions such as coronary artery disease, arrhythmias, and heart failure. Machine learning algorithms process echocardiograms, CT scans, and MRIs to deliver detailed insights into cardiac function and structure, enabling earlier and more accurate diagnosis. Additionally, AI-driven ECG analysis systems detect arrhythmias and other electrical anomalies in real time, improving outcomes by ensuring timely intervention.

In treatment planning, AI is enabling personalized care by analyzing patient-specific factors such as genetics, medical history, and lifestyle. Predictive models assess the risk of cardiovascular events, guiding physicians in tailoring preventive measures and treatment plans. These advancements underscore AI’s transformative role in improving the quality and efficiency of cardiology care.

What Drives the Adoption of AI in Cardiology?

The rising global burden of cardiovascular diseases (CVDs) is a significant driver of AI adoption in cardiology. CVDs remain the leading cause of death worldwide, necessitating innovative solutions to enhance prevention, diagnosis, and treatment. AI-powered tools provide healthcare professionals with the ability to identify high-risk patients early and implement preventive measures, reducing the prevalence and severity of these conditions.

The increasing availability of high-quality clinical data is another critical factor. Advances in data collection technologies, such as wearable devices, remote monitoring systems, and electronic health records, generate vast amounts of cardiovascular data. AI systems analyze this data to uncover actionable insights, enabling real-time monitoring and decision-making. These capabilities are particularly valuable in remote and resource-constrained settings, where access to specialized cardiology care may be limited.

Moreover, the integration of AI with telemedicine platforms is enhancing access to cardiology services. AI-driven tools support remote consultations by analyzing patient data and providing physicians with diagnostic recommendations. This integration is improving care accessibility and efficiency, especially in underserved regions. These trends highlight the growing reliance on AI as a critical component of modern cardiology practice.

Can AI Improve Patient Outcomes and Optimize Cardiovascular Care?

AI is playing a pivotal role in improving patient outcomes and optimizing the delivery of cardiovascular care. By enabling earlier and more accurate diagnosis, AI reduces the risk of complications and enhances the effectiveness of treatments. Predictive analytics tools identify patients at risk of conditions such as heart attacks and strokes, allowing healthcare providers to implement preventive measures and reduce mortality rates.

In surgical and interventional cardiology, AI is assisting in planning and execution. Robotic-assisted systems guided by AI improve the precision of procedures such as stent placement and valve replacement, minimizing risks and improving recovery outcomes. Additionally, AI-driven clinical decision support systems aid physicians in selecting the most appropriate therapies, ensuring optimal care for individual patients.

AI’s role in remote patient monitoring is also contributing to better outcomes. Wearable devices equipped with AI algorithms track vital signs such as heart rate and blood pressure, detecting early warning signs of deterioration. This real-time monitoring empowers patients to manage their conditions effectively while enabling physicians to intervene promptly when necessary. These advancements underscore AI’s potential to transform cardiovascular care and improve the lives of millions of patients worldwide.

What’s Driving the Growth of the AI in Cardiology Market?

The growth in the Artificial Intelligence in Cardiology market is driven by several key factors, reflecting its transformative potential in addressing cardiovascular health challenges. The increasing prevalence of cardiovascular diseases and the associated demand for advanced diagnostic and therapeutic solutions are significant growth drivers. AI-powered tools enhance the accuracy and efficiency of cardiology workflows, meeting the growing need for high-quality care.

Technological advancements in AI algorithms, coupled with the proliferation of wearable devices and remote monitoring systems, are enabling continuous innovation in the field. These tools generate real-time data, which AI systems analyze to deliver actionable insights and personalized care recommendations. Regulatory support for AI-driven medical devices and growing investments in healthcare technology are further fueling market expansion.

Consumer expectations for accessible and efficient healthcare are also contributing to the adoption of AI in cardiology. Patients are increasingly seeking tools that enable proactive health management, and AI solutions address this demand by offering predictive analytics and remote monitoring capabilities. These factors, combined with ongoing research and development, are propelling the rapid growth of the AI in Cardiology market, positioning it as a cornerstone of future advancements in cardiovascular care.

SCOPE OF STUDY

The report analyzes the Artificial Intelligence in Cardiology market by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Services Component, Software Component); Medical Condition (Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition, Other Medical Conditions); Application (Diagnosis Application, Drug Discovery Application, Prediction Application, Other Applications).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

CardiAI, Inc.; Cleerly, Inc.; IDOVEN; Koninklijke Philips NV; RSIP Vision; Tempus AI, Inc.; UltraSight; Ultromics Limited; Vista.ai; Viz

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

Tariff Impact on Global Supply Chain Patterns

Economic Frontiers: Trends, Trials & Transformations

Artificial Intelligence in Cardiology – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 36 Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

AI-Driven Cardiac Imaging Solutions Propel Growth in Early Diagnosis of Heart Conditions

Predictive Analytics in AI Strengthens Market for Risk Assessment in Cardiology

AI-Powered Wearable Devices Expand Opportunities in Remote Cardiac Monitoring

Advancements in AI-Enhanced ECG Analysis Drive Adoption in Diagnostic Centers

AI Algorithms for Detecting Heart Irregularities Strengthen Case for Faster Interventions

Integration of AI in Telecardiology Sets the Stage for Remote Healthcare Solutions

Demand for AI in Cardiac Rehabilitation Programs Spurs Adoption in Post-Care

AI Integration in Robotics for Cardiac Surgery Drives Demand in Minimally Invasive Techniques

Real-Time AI Insights for Blood Pressure Monitoring Propel Consumer Device Markets

AI in Remote Pacemaker Monitoring Highlights Consumer Health Potential

AI-Enhanced Cardiology Workflow Automation Drives Efficiency Across Hospitals

4. GLOBAL MARKET PERSPECTIVE

World Artificial Intelligence in Cardiology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Prediction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Prediction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Drug Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Drug Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Cardiac Arrhythmias Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Heart Failure Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Heart Failure Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Medical Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Medical Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

JAPAN

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

CHINA

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

EUROPE

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

FRANCE

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

GERMANY

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

UNITED KINGDOM

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

ASIA-PACIFIC

Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Accenture BV	%
Cleerly, Inc.	%
IDOVEN	%
Koninklijke Philips NV	%
RSIP Vision	%
Tempus AI, Inc.	%
UltraSight	%
Ultromics Limited	%
Vista.ai	%
Viz.ai Inc.	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll